APR 02, 2015 8:42 AM PDT

Clues into Cognitive Dysfunction in Chronic Fatigue Syndrome

WRITTEN BY: Ilene Schneider
Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) that provides insights into the basis for cognitive dysfunction-frequently described by patients as "brain fog"-as well as new hope for improvements in diagnosis and treatment.
Mady Hornig, MD, professor of Epidemiology at Columbia University's Mailman School of Public Health
In the study published in Molecular Psychiatry, Mady Hornig, MD, and colleagues used immunoassay testing methods to measure the levels of 51 immune biomarkers called cytokines in the cerebrospinal fluid of 32 people with ME/CFS for an average of seven years, 40 with multiple sclerosis, and 19 non-diseased controls. The researchers found that levels of most cytokines, including the inflammatory immune molecule, interleukin 1, were depressed in individuals with ME/CFS compared with the other two groups, matching what was seen in the blood study in patients who had the disease for more than three years. One cytokine-eotaxin-was elevated in the ME/CFS and MS groups, but not in the control group.

"We now know that the same changes to the immune system that we recently reported in the blood of people with ME/CFS with long-standing disease are also present in the central nervous system," says Dr. Hornig, professor of Epidemiology and director of translational research at the Center for Infection and Immunity at the Mailman School. "These immune findings may contribute to symptoms in both the peripheral parts of the body and the brain, from muscle weakness to brain fog."

Implications for Diagnosis and Treatment

"Diagnosis of ME/CFS is now based on clinical criteria. Our findings offer the hope of objective diagnostic tests for disease as well as the potential for therapies that correct the imbalance in cytokine levels seen in people with ME/CFS at different stages of their disease," adds W. Ian Lipkin, MD, John Snow Professor of Epidemiology and director of the Center for Infection and Immunity. There is precedent for use of human monoclonal antibodies that regulate the immune response in a wide range of disorders from rheumatoid arthritis to multiple sclerosis. However, the researchers note, additional work will be needed to assess the safety and efficacy of this approach.

Source: Columbia University
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
AUG 22, 2020
Neuroscience
Why Don't Babies Always Remember What they Learn?
AUG 22, 2020
Why Don't Babies Always Remember What they Learn?
Researchers from Ruhr- Universitaet Bochum (RUB) in Germany have found that the mood babies are in when they learn somet ...
AUG 25, 2020
Neuroscience
Study Shows Exercise Relieves Major Depression
AUG 25, 2020
Study Shows Exercise Relieves Major Depression
Depression is a common mental condition that many feel at some point throughout life. While antidepressants work for som ...
SEP 29, 2020
Cell & Molecular Biology
What We Call Parkinson's Disease May Actually be Two Distinct Disorders
SEP 29, 2020
What We Call Parkinson's Disease May Actually be Two Distinct Disorders
Researchers have used imaging tools to show that Parkinson's disease may actually be two different diseases, one that st ...
NOV 01, 2020
Neuroscience
High Fat Diet Could Prevent Anorexia Deaths
NOV 01, 2020
High Fat Diet Could Prevent Anorexia Deaths
Researchers from Yale University have homed in on a specific kind of neuron that appears to play a sizable role in fatal ...
NOV 08, 2020
Cannabis Sciences
Can Cannabis Treat Epilepsy?
NOV 08, 2020
Can Cannabis Treat Epilepsy?
There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, ther ...
NOV 15, 2020
Neuroscience
Brain Chemical Noradrenaline Helps Us Adapt to Uncertainty
NOV 15, 2020
Brain Chemical Noradrenaline Helps Us Adapt to Uncertainty
Researchers from the University of Cambridge and University College London have found that a neurochemical known as nora ...
Loading Comments...